Ian D Davis

33PUBLICATIONS

238CO-AUTHORS

Predictive and prognostic markersMolecular targetsPharmacogenomicsPacific Peoples community governance and decision makingRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|Jul 08, 2026

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|Jul 02, 2026

Germline CDK12 variants in aggressive prostate cancer.

|Jun 26, 2026

AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial.

|Apr 28, 2026

<sup>177</sup>Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer.

|Apr 15, 2026

Predictive value of early PSMA upregulation for the response to enzalutamide ± <sup>177</sup>Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trial.

|Mar 02, 2026

Management of Advanced Prostate Cancer in the Asia-Pacific Region: Summary of the Asia-Pacific Advanced Prostate Cancer Symposium 2025.

Edmund Chiong, Renu Eapen, Nicholas Buchan

Pageof 6

Frequent Collaborators

11 joint publications

Martin R Stockler

Anthony M Joshua

Shahneen Sandhu

Michael S Hofman

Christopher J Sweeney

Louise Emmett

Arun Azad

Kim N Chi

Edmond M Kwan

Haryana M Dhillon

Frequent Collaborators

11 joint publications

Martin R Stockler

7 joint publications

Anthony M Joshua

5 joint publications

Shahneen Sandhu

5 joint publications

Michael S Hofman